Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Post by dt_coreon Feb 16, 2024 1:31pm
147 Views
Post# 35884571

Well Health Could Offer 0.45 per share

Well Health Could Offer 0.45 per shareManaged to find time to do the math on a potential Well Health takeover of THNK. Based on where the company is trading now $3.70 and considering that some of Beedie capital converts would be in the money and thus convert to equity from debt the math tells me that Well Health could bid 0.45 per share. That assumes THNK 2024 Adj. EBITDA of $6.7M (current consensus) and also assumes Well could extract $2M in cost synergies (though I suspect it could be a lot more than that). If we assume cost synergies of $5M that purchase price goes up to 0.70 per share. 

Note that I'm assuming a cash deal from Well, and thus taking on additional debt which would push their leverage from current 2.6x Net Debt / Adj. EBITDA (2024) to 3.3x which I think is entirely doable, especially given THNKS pipeline which could take EBTIDA all the way up to $10-$14M for 2025.

The other potential player here is Telus Health and they are very well capitalized. 
<< Previous
Bullboard Posts
Next >>